NEW ENGLAND SURGICAL SOCIETY (EIN 066049051) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1916

Legal Domicile

Principal Officer

ROCCO ORLANDO III MD

Phone

9789278330

Tax Period

2023-01-01 to 2023-12-31

NEW ENGLAND SURGICAL SOCIETY, founded in 1916, is a small nonprofit that reported $261K in total revenue in fiscal year 2023. Revenue surged 26% from the prior year, signaling strong growth momentum. Expenses of $236K left a modest 9% surplus.

Mission

THE SOCIETY IS CONSTITUTED FOR THE PURPOSE OF PROMOTING THE SCIENCE OF SURGERY AND KINDRED ARTS AND SCIENCES AND THE WELFARE OF THE PROFESSION OF SURGERY IN NEW ENGLAND.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $10,500

Program Service Revenue $242,604

Investment Income $5,891

Other Revenue $1,531

TOTAL REVENUE $260,526

Expense Breakdown

Grants Paid $1,500

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $130,066

Other Expenses $234,630

TOTAL EXPENSES $236,130

Year-over-Year Comparison

	2023	2022	Change
Revenue	$260,526	$206,247	+0.3%
Expenses	$236,130	$225,707	+0.0%
Net Income	$24,396	$-19,460	-2.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ROCCO ORLANDO III MD	PRESIDENT/PR	2.00	Officer Director	$0	$0	$0
KARI ROSENKRANZ MD	PRESIDENT-EL	2.00	Officer Director	$0	$0	$0
M PARKER ROBERTS III MD	VICE PRES/RE	2.00	Officer Director	$0	$0	$0
JACUELINE J WU MD FACS	SECRETARY	2.00	Officer Director	$0	$0	$0
PETER S YOO MD	TREASURER	2.00	Officer Director	$0	$0	$0
ALI TAVAKKOLI MD FACS	RECORDER	2.00	Director	$0	$0	$0
GILES F WHALEN MD	IMM PAST PRE	2.00	Officer Director	$0	$0	$0
DAITHI S HEFFERNAN MD	REPRESENTITI	2.00	Director	$0	$0	$0
DAVID MCANENY MD FACS	REPRESENTITI	2.00	Director	$0	$0	$0
ALAN K MEINKE MD	REPRESENTITI	2.00	Director	$0	$0	$0
MITCHELL C NOROTSKY MD	REPRESENTATI	2.00	Director	$0	$0	$0
PAIGE TELLER MD	REPRESENTATI	2.00	Director	$0	$0	$0
BRENT C WHITE MD	REPRESENTATI	2.00	Director	$0	$0	$0
ERIKA L RANGEL MD	REP TO ACS B	2.00	Director	$0	$0	$0
JOHN J KELLY MD	REP TO ACS A	2.00	Director	$0	$0	$0
KATHLEEN A LAVORGNA MD	VICE PRES(10	2.00	Officer Director	$0	$0	$0
THOMAS J MINER MD	SECRETARY(10	2.00	Officer Director	$0	$0	$0
JAMES WHITING MD	IMM PAST PRE	2.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$260,526	$236,130	$458,071	$24,396
2022	$206,247	$225,707	$397,277	$-19,460
2021	$245,879	$192,680	$456,880	$53,199
2019	$213,535	$238,912	$362,355	$-25,377
2018	$239,196	$238,485	$368,077	$711

NEW ENGLAND SURGICAL SOCIETY